Hidetaka Onda , Mizuki Kojima , Nodoka Miyake , Kenta Shigeta , Naoki Tominaga , Shoji Yokobori
{"title":"Association between postoperative interleukin-6 levels in cerebrospinal fluid and invasiveness of surgery for subarachnoid hemorrhage","authors":"Hidetaka Onda , Mizuki Kojima , Nodoka Miyake , Kenta Shigeta , Naoki Tominaga , Shoji Yokobori","doi":"10.1016/j.wnsx.2025.100511","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Interleukin (IL)-6 levels in cerebrospinal fluid (CSF) may reflect postoperative inflammation and affect the outcomes of aneurysmal subarachnoid hemorrhage (SAH).</div></div><div><h3>Methods</h3><div>This study retrospectively analyzed CSF IL-6 levels on the first postoperative day in 77 patients with SAH treated by craniotomy or endovascular coiling within 12 h of diagnosis. IL-6 levels were measured by enzyme-linked immunosorbent assay and compared between treatment groups. Associations with cerebral vasospasm and clinical outcomes were evaluated by multiple regression analysis.</div></div><div><h3>Results</h3><div>The median IL-6 level in CSF was 10,501 pg/mL [interquartile range 3037.8, 43,118.5] and was significantly lower in the endovascular group than in the craniotomy group (<em>p</em> < 0.001). In the craniotomy group, the IL-6 level was higher in patients with involvement of the anterior communicating artery than in those with aneurysm at other sites (<em>p</em> = 0.008). Cerebral vasospasm was identified in 13.0 % of cases and was associated with elevated IL-6 (<em>p</em> = 0.003). Higher IL-6 levels were correlated with unfavorable outcomes (<em>p</em> < 0.001).</div></div><div><h3>Conclusion</h3><div>Elevated IL-6 levels in CSF on postoperative day 1 were associated with cerebral vasospasm and worse outcomes in patients with SAH. Endovascular treatment resulted in lower IL-6 levels, suggesting that minimally invasive methods may reduce inflammation and improve the prognosis. Regulating IL-6 could be a potential therapeutic strategy in SAH management.</div></div>","PeriodicalId":37134,"journal":{"name":"World Neurosurgery: X","volume":"28 ","pages":"Article 100511"},"PeriodicalIF":2.5000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Neurosurgery: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590139725000857","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/22 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Interleukin (IL)-6 levels in cerebrospinal fluid (CSF) may reflect postoperative inflammation and affect the outcomes of aneurysmal subarachnoid hemorrhage (SAH).
Methods
This study retrospectively analyzed CSF IL-6 levels on the first postoperative day in 77 patients with SAH treated by craniotomy or endovascular coiling within 12 h of diagnosis. IL-6 levels were measured by enzyme-linked immunosorbent assay and compared between treatment groups. Associations with cerebral vasospasm and clinical outcomes were evaluated by multiple regression analysis.
Results
The median IL-6 level in CSF was 10,501 pg/mL [interquartile range 3037.8, 43,118.5] and was significantly lower in the endovascular group than in the craniotomy group (p < 0.001). In the craniotomy group, the IL-6 level was higher in patients with involvement of the anterior communicating artery than in those with aneurysm at other sites (p = 0.008). Cerebral vasospasm was identified in 13.0 % of cases and was associated with elevated IL-6 (p = 0.003). Higher IL-6 levels were correlated with unfavorable outcomes (p < 0.001).
Conclusion
Elevated IL-6 levels in CSF on postoperative day 1 were associated with cerebral vasospasm and worse outcomes in patients with SAH. Endovascular treatment resulted in lower IL-6 levels, suggesting that minimally invasive methods may reduce inflammation and improve the prognosis. Regulating IL-6 could be a potential therapeutic strategy in SAH management.